<?xml version="1.1" encoding="utf-8"?>
<rdf:RDF xmlns:OMEXlib="http://omex-library.org/"
   xmlns:bqbiol="http://biomodels.net/biology-qualifiers/"
   xmlns:bqmodel="http://biomodels.net/model-qualifiers/"
   xmlns:dc="http://purl.org/dc/terms/"
   xmlns:foaf="http://xmlns.com/foaf/0.1/"
   xmlns:local="http://omex-library.org/NewOmex.omex/NewModel.rdf#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/BIOMD0000000178.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00001"/>
    <bqmodel:isDescribedBy rdf:resource="local:00002"/>
    <ns1:keyword xmlns:ns1="http://prismstandard.org/namespaces/basic/2.0/">Biomodels</ns1:keyword>
    <ns2:title xmlns:ns2="http://purl.org/dc/elements/1.1/">Onset dynamics of type A botulinum neurotoxin-induced paralysis</ns2:title>
    <ns3:thumbnail xmlns:ns3="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000000178.omex/BIOMD0000000178.png"/>
    <ns4:thumbnail xmlns:ns4="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000000178.omex/curation_image.png"/>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <ns5:identifier xmlns:ns5="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/doi/10.1007/s10928-008-9087-3"/>
    <ns6:label xmlns:ns6="http://www.w3.org/2000/01/rdf-schema#">Frank J. Lebeda, Michael Adler, Keith Erickson &amp; Yaroslav Chushak. Onset dynamics of type A botulinum neurotoxin-induced paralysis. Journal of Pharmacokinetics and Pharmacodynamics 35, 3 (2008).</ns6:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <ns7:identifier xmlns:ns7="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/pubmed/6243359"/>
    <ns8:label xmlns:ns8="http://www.w3.org/2000/01/rdf-schema#">Simpson LL. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. The Journal of pharmacology and experimental therapeutics 212, 1: 16-21 (1980).</ns8:label>
  </rdf:Description>
</rdf:RDF>

